Companies / ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

Nasdaq: NDRACIK 1681682ANN ARBOR, MI

Financials · FY2020

Revenue$0
Net income$-7.03M
Total debt$0
Cash$4.82M
Diluted EPS$-8.93
Shares outstanding1.3M

Ownership

1.3M shares outstanding · as of May 15, 2026
31.8%Insiders
Ownership
Insiders31.76%403,395
Institutions9.55%121,306
Public float58.69%745,376

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
10.75%136,589
Tokman Alexander YCEOChief Executive Officer · Director
8.03%101,926
5.17%65,710
Basenese LouDirector
5.17%65,709
Jacroux RichardChief Financial Officer
2.63%33,461

Institutional holders 10

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 21, 2026Basenese Lou
Director
GrantCommon Stock$0+60K
+1120.22%
65,709
5.17% of shares
low
Jan 21, 2026Harsh Michael
Director
GrantCommon Stock$0+60K
+1120.01%
65,710
5.17% of shares
low
Mar 2, 2026Tokman Alexander Y
CEO
GrantCommon Stock$0+27K
+35.89%
101,926
8.03% of shares
low
Mar 2, 2026Jacroux Richard
Executive
GrantCommon Stock$0+13K
+67.31%
33,461
2.63% of shares
low
Jan 21, 2026Anthony DiGiandomenico
Director
GrantCommon Stock$0+60K
+79.10%
136,589
10.75% of shares
low
Jan 21, 2026Jacroux Richard
Executive
GrantCommon Stock$0+20K
20,000
1.57% of shares
low
Jan 21, 2026Tokman Alexander Y
CEO
GrantCommon Stock$0+75K
+1500000.00%
75,005
5.91% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NDRACommon StockEquity29273B500BBG00FD4RCV3